Versant Venture Management, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 67 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,125,178
-11.8%
3,561,1500.0%3.26%
-60.5%
Q2 2023$6,944,243
-29.9%
3,561,1500.0%8.24%
-60.1%
Q1 2023$9,899,997
-19.4%
3,561,1500.0%20.64%
-18.8%
Q4 2022$12,285,968
+34.2%
3,561,1500.0%25.42%
+62.9%
Q3 2022$9,152,000
+6.2%
3,561,1500.0%15.60%
+18.1%
Q2 2022$8,618,000
-41.3%
3,561,1500.0%13.21%
-9.8%
Q1 2022$14,672,000
-68.0%
3,561,1500.0%14.65%
-40.2%
Q4 2021$45,796,000
+5.9%
3,561,150
-11.1%
24.49%
+36.7%
Q3 2021$43,264,000
+6.5%
4,005,894
-10.0%
17.91%
+33.1%
Q2 2021$40,634,000
-3.2%
4,450,6380.0%13.46%
+64.7%
Q1 2021$41,970,000
+139.3%
4,450,6380.0%8.18%
+349.0%
Q4 2020$17,536,000
+113.3%
4,450,638
+43.4%
1.82%
+21.0%
Q3 2020$8,223,000
-100.0%
3,102,9290.0%1.50%
-49.2%
Q2 2020$20,603,449,000
+14.1%
3,102,9290.0%2.96%
-40.2%
Q1 2020$18,059,047,000
-35.1%
3,102,9290.0%4.95%
-40.9%
Q4 2019$27,833,273,000
+3.9%
3,102,9290.0%8.39%
-19.1%
Q3 2019$26,793,792,000
-22.5%
3,102,9290.0%10.37%
+2.9%
Q2 2019$34,566,629,0003,102,92910.07%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders